A股異動 | 風華高科(000636.SZ)漲停 上半年淨利同比預增85%-104%
格隆匯7月12日丨風華高科(000636.SZ)漲停,封單逾7萬手,現報36.62元,暫成交26億元,最新市值327.8億元。風華高科上週五(9日)晚間公佈,預計2021年半年度歸屬於上市公司股東的淨利潤4.7億元-5.2億元,同比增長84.74%-104.4%。報吿期,受益於電子元器件市場需求旺盛、公司前期投資成效逐步釋放以及強化管控等綜合因素的積極影響,公司主營產品產銷同比大幅增長,公司營業收入及經營業績同比持續增長。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.